Andreas Pahl

Andreas Pahl

Director Ejecutivo en
Heidelberg Pharma Research GmbH
.
Health Technology
Consumer Services
Commercial Services

Perfil

Andreas Pahl is currently Managing Director at Heidelberg Pharma Research GmbH since 2024.
Former positions include Chief Executive Officer at Heidelberg Pharma AG from 2024 to 2025, Head-Late Pharmacology at Takeda Pharmaceutical Co., Ltd., Professor-Pharmacology & Toxicology at Friedrich-Alexander University of Erlangen-Nuremberg, Professor at Technical University of Berlin, Chief Scientific Officer at Heidelberg Pharma AG, Head-Late Pharmacology at Nycomed GmbH, and Member of the Supervisory Board at Emergence Therapeutics AG.
Education includes undergraduate studies at Humboldt-Universität zu Berlin.

Cargos activos de Andreas Pahl

EmpresasCargoInicio
Director Ejecutivo 01/02/2024

Antiguos cargos conocidos de Andreas Pahl.

EmpresasCargoFin
HEIDELBERG PHARMA AG Director Ejecutivo 24/11/2025
Corporate Officer/Principal -
TAKEDA PHARMACEUTICAL COMPANY LIMITED Corporate Officer/Principal -
Director/Miembro de la Junta -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Andreas Pahl.

Formación de Andreas Pahl.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

12

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas9

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Commercial Services

Health Technology